A citation-based method for searching scientific literature


List of co-cited articles
54 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



EGFR TKIs impair lysosome-dependent degradation of SQSTM1 to compromise the effectiveness in lung cancer.
Lixian Yang, Shilong Ying, Shiman Hu, Xiangtong Zhao, Muchun Li, Miaoqin Chen, Yiran Zhu, Ping Song, Liyuan Zhu, Tingting Jiang,[...]. Signal Transduct Target Ther 2019
12
8

Liquid biopsy for detection of EGFR T790M mutation in nonsmall cell lung cancer: An experience of proficiency testing in Taiwan.
Hsiang-Ling Ho, Chao-Cheng Huang, Wen-Hui Ku, Chung-Liang Ho, Chia-Hung Lin, Sung-Liang Yu, Teh-Ying Chou. J Chin Med Assoc 2019
3
33

Targeting the IL-1β/EHD1/TUBB3 axis overcomes resistance to EGFR-TKI in NSCLC.
Jian Huang, Xiuwen Lan, Ting Wang, Hailing Lu, Mengru Cao, Shi Yan, Yue Cui, Dexin Jia, Li Cai, Ying Xing. Oncogene 2020
14
7

Metformin-sensitized NSCLC cells to osimertinib via AMPK-dependent autophagy inhibition.
Hengyi Chen, Caiyu Lin, Conghua Lu, Yubo Wang, Rui Han, Li Li, Shuai Hao, Yong He. Clin Respir J 2019
9
11


The epidermal growth factor receptor-tyrosine kinase inhibitor era has changed the causes of death of patients with advanced non-small-cell lung cancer.
Wen-Shuo Wu, Yuh-Min Chen, Chun-Ming Tsai, Jen-Fu Shih, Yu-Chin Lee, Reury-Perng Perng, Jacqueline Whang-Peng. J Chin Med Assoc 2013
5
20


A consensus on the role of osimertinib in non-small cell lung cancer from the AME Lung Cancer Collaborative Group.
Tao Jiang, Chunxia Su, Shengxiang Ren, Federico Cappuzzo, Gaetano Rocco, Joshua D Palmer, Nico van Zandwijk, Fiona Blackhall, Xiuning Le, Nathan A Pennell,[...]. J Thorac Dis 2018
23
6

The T790M resistance mutation in EGFR is only found in cfDNA from erlotinib-treated NSCLC patients that harbored an activating EGFR mutation before treatment.
Christina Demuth, Anne Tranberg Madsen, Britta Weber, Lin Wu, Peter Meldgaard, Boe Sandahl Sorensen. BMC Cancer 2018
10
10

Intrinsic resistance to EGFR-Tyrosine Kinase Inhibitors in EGFR-Mutant Non-Small Cell Lung Cancer: Differences and Similarities with Acquired Resistance.
Eric Santoni-Rugiu, Linea C Melchior, Edyta M Urbanska, Jan N Jakobsen, Karin de Stricker, Morten Grauslund, Jens B Sørensen. Cancers (Basel) 2019
58
6

An angiopoietin-like protein 2 autocrine signaling promotes EMT during pancreatic ductal carcinogenesis.
Carmine Carbone, Geny Piro, Matteo Fassan, Anna Tamburrino, Maria Mihaela Mina, Marco Zanotto, Paul J Chiao, Claudio Bassi, Aldo Scarpa, Giampaolo Tortora,[...]. Oncotarget 2015
36
6

A Comprehensive Review on MAPK: A Promising Therapeutic Target in Cancer.
Cornelia Braicu, Mihail Buse, Constantin Busuioc, Rares Drula, Diana Gulei, Lajos Raduly, Alexandru Rusu, Alexandru Irimie, Atanas G Atanasov, Ondrej Slaby,[...]. Cancers (Basel) 2019
206
6

Lung cancer.
Roy S Herbst, John V Heymach, Scott M Lippman. N Engl J Med 2008
6

Soluble Ig-like transcript 3 inhibits tumor allograft rejection in humanized SCID mice and T cell responses in cancer patients.
Nicole Suciu-Foca, Nikki Feirt, Qing-Yin Zhang, George Vlad, Zhuoru Liu, Hana Lin, Chih-Chao Chang, Eric K Ho, Adriana I Colovai, Howard Kaufman,[...]. J Immunol 2007
68
6

High expression of ILT3 and ILT4 is a general feature of tolerogenic dendritic cells.
John S Manavalan, Paola C Rossi, George Vlad, Flavia Piazza, Anna Yarilina, Raffaello Cortesini, Donna Mancini, Nicole Suciu-Foca. Transpl Immunol 2003
235
6

The Impact of Smoking and TP53 Mutations in Lung Adenocarcinoma Patients with Targetable Mutations-The Lung Cancer Mutation Consortium (LCMC2).
Dara L Aisner, Lynette M Sholl, Lynne D Berry, Michael R Rossi, Heidi Chen, Junya Fujimoto, Andre L Moreira, Suresh S Ramalingam, Liza C Villaruz, Gregory A Otterson,[...]. Clin Cancer Res 2018
99
6

Expression of inhibitory receptor ILT3 on neoplastic B cells is associated with lymphoid tissue involvement in chronic lymphocytic leukemia.
Adriana I Colovai, Lawrence Tsao, Su Wang, Hana Lin, Chuan Wang, Tetsunori Seki, Julie G Fisher, Manuel Menes, Govind Bhagat, Bachir Alobeid,[...]. Cytometry B Clin Cytom 2007
37
6

AKT as a Therapeutic Target for Cancer.
Mengqiu Song, Ann M Bode, Zigang Dong, Mee-Hyun Lee. Cancer Res 2019
227
6

LILRB4 signalling in leukaemia cells mediates T cell suppression and tumour infiltration.
Mi Deng, Xun Gui, Jaehyup Kim, Li Xie, Weina Chen, Zunling Li, Licai He, Yuanzhi Chen, Heyu Chen, Weiguang Luo,[...]. Nature 2018
82
6

ILT3.Fc-CD166 Interaction Induces Inactivation of p70 S6 Kinase and Inhibits Tumor Cell Growth.
Zheng Xu, Chih-Chao Chang, Muyang Li, Qing-Yin Zhang, Elena-Rodica M Vasilescu, Vivette D'Agati, Aristidis Floratos, George Vlad, Nicole Suciu-Foca. J Immunol 2018
19
6

Immunoglobulin-like transcript 3: A crucial regulator of dendritic cell function.
George Vlad, Chih-Chao Chang, Adriana I Colovai, Pasquale Berloco, Raffaello Cortesini, Nicole Suciu-Foca. Hum Immunol 2009
35
6


EMT and Cancer: More Than Meets the Eye.
Rik Derynck, Robert A Weinberg. Dev Cell 2019
102
6

Overexpressed immunoglobulin-like transcript (ILT) 4 in lung adenocarcinoma is correlated with immunosuppressive T cell subset infiltration and poor patient outcomes.
Qing Li, Juan Li, Shuyun Wang, Jingnan Wang, Xiaozheng Chen, Dongmei Zhou, Yuying Fang, Aiqin Gao, Yuping Sun. Biomark Res 2020
7
14



Cancer statistics, 2015.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2015
6


Inhibitory leukocyte immunoglobulin-like receptors: Immune checkpoint proteins and tumor sustaining factors.
Xunlei Kang, Jaehyup Kim, Mi Deng, Samuel John, Heyu Chen, Guojin Wu, Hiep Phan, Cheng Cheng Zhang. Cell Cycle 2016
86
6

EMT: A mechanism for escape from EGFR-targeted therapy in lung cancer.
Eugene Tulchinsky, Oleg Demidov, Marina Kriajevska, Nickolai A Barlev, Evgeny Imyanitov. Biochim Biophys Acta Rev Cancer 2019
72
6

Expression of immunoglobulin-like transcript (ILT)2 and ILT3 in human gastric cancer and its clinical significance.
Yi Zhang, Nan Lu, Yuwen Xue, Min Zhang, Yingjie Li, Yuanquan Si, Xiaokun Bian, Yanfei Jia, Yunshan Wang. Mol Med Rep 2012
58
6


The war on cancer.
M B Sporn. Lancet 1996
457
6

New targetable oncogenes in non-small-cell lung cancer.
Geoffrey R Oxnard, Adam Binder, Pasi A Jänne. J Clin Oncol 2013
239
6

Dynamic intracellular survivin in oral squamous cell carcinoma: underlying molecular mechanism and potential as an early prognostic marker.
K Engels, S K Knauer, D Metzler, C Simf, O Struschka, C Bier, W Mann, A F Kovács, R H Stauber. J Pathol 2007
94
6

Crystal structure of leukocyte Ig-like receptor LILRB4 (ILT3/LIR-5/CD85k): a myeloid inhibitory receptor involved in immune tolerance.
Hao Cheng, Fiyaz Mohammed, Gol Nam, Yong Chen, Jianxun Qi, Lee I Garner, Rachel L Allen, Jinghua Yan, Benjamin E Willcox, George F Gao. J Biol Chem 2011
30
6

ILT4 functions as a potential checkpoint molecule for tumor immunotherapy.
Aiqin Gao, Yuping Sun, Guangyong Peng. Biochim Biophys Acta Rev Cancer 2018
20
6

Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma.
N Weidner, J P Semple, W R Welch, J Folkman. N Engl J Med 1991
6

Emerging Roles of Apolipoprotein E and Apolipoprotein A-I in the Pathogenesis and Treatment of Lung Disease.
Xianglan Yao, Elizabeth M Gordon, Debbie M Figueroa, Amisha V Barochia, Stewart J Levine. Am J Respir Cell Mol Biol 2016
62
6

Pharmacological induction of tolerogenic dendritic cells and regulatory T cells.
Luciano Adorini, Nadia Giarratana, Giuseppe Penna. Semin Immunol 2004
147
6

LILRB receptor-mediated regulation of myeloid cell maturation and function.
William van der Touw, Hui-Ming Chen, Ping-Ying Pan, Shu-Hsia Chen. Cancer Immunol Immunother 2017
49
6

Angiopoietin-like protein 2 facilitates non-small cell lung cancer progression by promoting the polarization of M2 tumor-associated macrophages.
Xiaojuan Wei, Siyue Nie, Hui Liu, Jingyu Sun, Jie Liu, Juan Li, Shuyan Li, Shuyun Wang, Shuyi Han, Jun Wang,[...]. Am J Cancer Res 2017
11
9

B7-H3 promotes aggression and invasion of hepatocellular carcinoma by targeting epithelial-to-mesenchymal transition via JAK2/STAT3/Slug signaling pathway.
Fu-Biao Kang, Ling Wang, Heng-Chuan Jia, Dong Li, Hai-Jun Li, Yin-Ge Zhang, Dian-Xing Sun. Cancer Cell Int 2015
92
6

Personalized therapy for lung cancer: striking a moving target.
Suchita Pakkala, Suresh S Ramalingam. JCI Insight 2018
64
6


Targeting SHP-1, 2 and SHIP Pathways: A Novel Strategy for Cancer Treatment?
Wolfram C M Dempke, Peter Uciechowski, Klaus Fenchel, Timothy Chevassut. Oncology 2018
27
6

Decidual Macrophage Functional Polarization during Abnormal Pregnancy due to Toxoplasma gondii: Role for LILRB4.
Zhidan Li, Mingdong Zhao, Teng Li, Jing Zheng, Xianbing Liu, Yuzhu Jiang, Haixia Zhang, Xuemei Hu. Front Immunol 2017
22
6


Resistance Mechanisms to Targeted Therapies in ROS1+ and ALK+ Non-small Cell Lung Cancer.
Caroline E McCoach, Anh T Le, Katherine Gowan, Kenneth Jones, Laura Schubert, Andrea Doak, Adriana Estrada-Bernal, Kurtis D Davies, Daniel T Merrick, Paul A Bunn,[...]. Clin Cancer Res 2018
107
6


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.